|Articles|August 20, 2020

COVID-19 vaccine distribution to begin by January 2021

Two senior administration officials from Operation Warp Speed offered several updates on COVID-19 vaccine development.

At Operation Warp Speed (OWS)’s most recent briefing on August 13, Paul Mango, Deputy Chief of Staff for Policy at the Department of Health and Human Services (HHS) and secretary principal executive at OWS, and Francis Collins, MD, PhD, Director of the National Institutes of Health (NIH) discussed the distribution timeline for a vaccine in the US.

According to our sister publication, Drug Topics, “The most significant steps forward since the last briefing include the expansion of many agreements in the private sector, which are working to develop COVID-19 vaccines in the form of support for manufacturing work.”

For additional coverage, head over to Drug Topics.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

October 29th, 2026

Susan Reed, MD, on the future of menopause research and funding

Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.

October 29th, 2026

Chrisandra Shufelt, MD, on cardiovascular prevention at menopause

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.

October 28th, 2026

Matthew Nudy, MD, on estrogen and the cardiovascular system

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

October 28th, 2026

ACOG advises against GLP-1 receptor agonists during pregnancy

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

October 27th, 2026

Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause

Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.

October 27th, 2026

Multi-society framework ties cardiovascular risk to female life stages

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

October 26th, 2026

Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.